May 7, 2021 Price forecast | 2 weeks: -2.65% | 1 month: -5.04% | 3 months: -3.55%


TARS stock forecast

Our latest prediction for Tarsus Pharmaceuticals Inc's stock price was made on the May 7, 2021 when the stock price was at 29.98$.

In the short term (2weeks), TARS's stock price should underperform the market by -2.65%. During that period the price should oscillate between -12.04% and +10.72%.

In the medium term (3months), TARS's stock price should underperform the market by -3.55%. During that period the price should oscillate between -38.34% and +32.03%.

Create a solid portfolio with TARS

Add TARS to your portfolio and optimize it!


About Tarsus Pharmaceuticals Inc

Tarsus Pharmaceuticals, Inc. is a late clinical-stage biopharmaceutical company that applies proven science and new technology to revolutionize treatment for patients, starting with eye care. It is advancing its pipeline to address a number of diseases with high unmet need across a range of therapeutic categories, including eye care, dermatology, and infectious disease prevention. Its lead product candidate, TP-03, is a novel therapeutic in Phase 2b/3 for the treatment of Demodex blepharitis. TP-03 is also being developed for the treatment of Meibomian Gland Disease.

At the moment the company doesn't generate any revenue.

On its last earning announcement, the company reported a loss of -4.32$ per share.

The book value per share is 8.02$

Tarsus Pharmaceuticals Inc website


Three months stock forecastMay 7, 2021


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
- - -27M - -27M -4.32 - - 6M 8.02 -21M - -22M